Hou‐Wei Chu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Genetics top 10%
- Genetic Associations and Epidemiology
Papers in
- Genetics 13
- Genetic Associations and Epidemiology 10
- BRCA gene mutations in cancer 2
- Forensic and Genetic Research 2
-
- MicroRNA in disease regulation 4
- Breast Cancer Treatment Studies 2
- Co-authors
- Chen‐Yang Shen (15 shared papers)Pei‐Ei Wu (8 shared papers)Chia‐Ni Hsiung (6 shared papers)Wen‐Cheng Chou (7 shared papers)Jui‐I Chao (2 shared papers)Jenn-Hwai Yang (2 shared papers)Chien-Hsiun Chen (2 shared papers)Fu‐Tong Liu (1 shared paper)
- Journals
- Human Molecular Genetics (3 papers)Clinical Epigenetics (2 papers)Scientific Reports (2 papers)PLoS ONE (2 papers)Molecular Biology and Evolution (1 paper)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Hou‐Wei Chu
24 papers receiving 981 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 253
- Genetics 249
- Nephrology 82
- Health, Toxicology and Mutagenesis 51
- Oncology 58
Countries citing papers authored by Hou‐Wei Chu
This map shows the geographic impact of Hou‐Wei Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hou‐Wei Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hou‐Wei Chu more than expected).
Fields of papers citing papers by Hou‐Wei Chu
This network shows the impact of papers produced by Hou‐Wei Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hou‐Wei Chu. The network helps show where Hou‐Wei Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hou‐Wei Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 247 | |
| 2 | 2012 | 179 | |
| 3 | 2022 | 116 | |
| 4 | 2018 | 58 | |
| 5 | 2013 | 51 | |
| 6 | 2016 | 48 | |
| 7 | 2015 | 42 | |
| 8 | 2019 | 37 | |
| 9 | 2020 | 24 | |
| 10 | 2020 | 21 | |
| 11 | 2015 | 20 | |
| 12 | 2019 | 20 | |
| 13 | 2020 | 18 | |
| 14 | 2019 | 17 | |
| 15 | 2022 | 17 | |
| 16 | 2020 | 16 | |
| 17 | 2022 | 13 | |
| 18 | 2020 | 12 | |
| 19 | 2019 | 11 | |
| 20 | 2020 | 10 |
About Hou‐Wei Chu
Hou‐Wei Chu is a scholar working on Genetics, Cancer Research, Endocrinology, Diabetes and Metabolism, Molecular Biology and Orthopedics and Sports Medicine, having authored 24 papers that have together received 996 indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (10 papers), MicroRNA in disease regulation (4 papers), Epigenetics and DNA Methylation (2 papers), BRCA gene mutations in cancer (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Forensic and Genetic Research (2 papers), Breast Cancer Treatment Studies (2 papers) and Bone health and osteoporosis research (1 paper). The work is most often cited by research in Cancer Research (253 citations), Genetics (249 citations), Nephrology (82 citations), Health, Toxicology and Mutagenesis (51 citations) and Oncology (58 citations). Hou‐Wei Chu has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Chen‐Yang Shen, Pei‐Ei Wu, Chia‐Ni Hsiung, Wen‐Cheng Chou, Jui‐I Chao, Jenn-Hwai Yang, Chien-Hsiun Chen, Fu‐Tong Liu, I-Wen Song and Yuan-Tsong Chen. Their work appears in journals such as Human Molecular Genetics, Clinical Epigenetics, Scientific Reports, PLoS ONE and Molecular Biology and Evolution.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.